Early studies suggest that adding high-dose vitamin B3 (niacin) to standard treatments for glioblastoma may improve immune activity and disease control. While promising, researchers emphasize the need for caution and larger studies.
Early preclinical studies suggest that high-dose vitamin B3, also known as niacin, may enhance immune activity and improve short-term disease control in glioblastoma when used in conjunction with standard therapy. Glioblastoma is a particularly aggressive and rapidly growing form of brain cancer, originating from cells within the brain and spinal cord. Prior laboratory experiments conducted on mice demonstrated that niacin could extend survival rates.
Researchers at the University of Calgary initiated a study to determine whether the same positive effects could be replicated in human subjects. This research highlights the potential of niacin as a supplemental treatment, offering a glimpse of hope in the fight against this devastating disease. The findings are significant, considering the historically limited treatment options and poor prognosis associated with glioblastoma. The investigation's design aimed to assess the impact of niacin on patients undergoing conventional treatments, including surgery, radiation, and chemotherapy. This approach allows for a direct comparison of patient outcomes with and without the addition of niacin, which is crucial in evaluating the effectiveness of the treatment. The research team's commitment to further investigation underscores their dedication to advancing treatment options for those affected by this challenging form of cancer.\The clinical trials involved a cohort of 24 patients diagnosed with glioblastoma. This particular cancer type is known for its aggressive nature and typically has a median survival duration of approximately 12 to 18 months. Six months following the integration of niacin into their standard treatment protocols (encompassing surgery, radiation, and chemotherapy), an impressive 82% of the patients exhibited no signs of disease progression. This outcome represents a notable improvement when compared to the typical rate of 54% observed in standard treatments alone, according to the study's press release. Furthermore, the study revealed that niacin was instrumental in restoring functionality to weakened immune cells. This revitalization enhanced the immune cells' ability to identify and eliminate tumor cells. These findings, including the significant 28% improvement in disease progression rates, were published in the esteemed Journal of Neuro-Oncology. Dr. Wee Yong, a prominent neuroscientist specializing in the study of immune responses within the brain, and the study's author, emphasized that glioblastoma has the capacity to suppress the body's natural immune defenses. Niacin treatment, in contrast, appears to reinvigorate immune cells, enabling them to effectively combat and eliminate cancerous cells. The team's perspective likens this ongoing process to a persistent battle waged within the brain, as it seeks to outmaneuver the disease. The research team has plans to recruit another 24 patients by the conclusion of 2026 or the beginning of 2027 to assess the safety aspects and the immune system activation capabilities of niacin.\While the early results appear promising, researchers have emphasized the need for caution. Glioblastoma is recognized as the most aggressive form of brain cancer affecting adults, and survival rates have remained largely unchanged for the past two decades. The researchers emphasize that given the limited treatment options and historically poor outcomes associated with glioblastoma, any potential intervention with the potential to offer improvement should be considered and explored, but with very strict monitoring and protocol. This underscores the need for rigorous research methods and careful evaluation of the treatment's impact. The study’s limitations included a small sample size, a short follow-up period, and a lack of a randomized control group, necessitating further, larger-scale trials to validate the findings fully. The researchers also highlighted the importance of doctor-supervised use due to the potential health risks associated with high doses of vitamins. Dr. Marc Siegel, a senior medical analyst, pointed out niacin's potential side effects, such as skin blushing. He added that the findings provide useful information and are helpful for patients, while acknowledging that it is clearly not a cure. The ongoing investigation and the planned future phases will be crucial in determining the long-term efficacy and safety of niacin as an adjunct treatment for glioblastoma. The scientific community and the medical field recognize the need for additional research to confirm these early indications and to develop optimal treatment strategies to improve patient outcomes
Glioblastoma Niacin Vitamin B3 Cancer Treatment Immune System
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Whitney Houston made a heartbreaking final promise hours before her deathRight before Whitney Houston passed away in 2012 at age 48, she spent three hours on the phone with fellow R&B singer Brandy, during which she made a promise.
Read more »
Birdville Stadium shooting: Suspect lured victims with promise of money during custody disputeThe suspect in last week's fatal shooting near Birdville ISD Stadium was in a custody dispute with the adult victim, Haltom City Police have learned.
Read more »
Victim in deadly Chinatown crash ID'd, city officials promise new safety measuresThe Chinatown restaurant on Jackson Street where a vehicle crashed and hit two people was boarded up on Monday.
Read more »
Dodgers' Roki Sasaki shows promise after horrid spring trainingAfter a disastrous spring training, Dodgers pitcher Roki Sasaki showed promise in his first start of the season, limiting the Guardians to one run while striking out four.
Read more »
Democrats pounce on $4 a gallon gas, blame Trump’s Iran war for ‘broken promise’Fox News Channel offers its audiences in-depth news reporting, along with opinion and analysis encompassing the principles of free people, free markets and diversity of thought, as an alternative to the left-of-center offerings of the news marketplace.
Read more »
Aggressive brain cancer may respond to high-dose vitamin therapy, study suggestsFox News Channel offers its audiences in-depth news reporting, along with opinion and analysis encompassing the principles of free people, free markets and diversity of thought, as an alternative to the left-of-center offerings of the news marketplace.
Read more »